<DOC>
<DOCNO>EP-0614893</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Benzoxazine derivatives, their preparation and their use in therapy
</INVENTION-TITLE>
<CLASSIFICATIONS>C07D41314	A61P900	A61P910	C07D26500	A61P2702	A61P3500	C07D26536	C07D41306	A61K31535	A61K31535	A61P2500	A61K315375	A61P2528	C07D41300	A61K31538	C07D41312	A61P2700	A61P2500	A61P3500	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>C07D	A61P	A61P	C07D	A61P	A61P	C07D	C07D	A61K	A61K	A61P	A61K	A61P	C07D	A61K	C07D	A61P	A61P	A61P	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>C07D413	A61P9	A61P9	C07D265	A61P27	A61P35	C07D265	C07D413	A61K31	A61K31	A61P25	A61K31	A61P25	C07D413	A61K31	C07D413	A61P27	A61P25	A61P35	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
Compounds corresponding to the general formula (I) 
<
IMAGE
>
 in which Y represents a hydrogen, fluorine or chlorine atom or a methyl or methoxy group, R1 represents either a phenyl group substituted by a fluorine atom or by a group chosen from the methyl, methoxy, trifluoromethyl and phenyl groups or represents a 2-thienyl group, R2 represents a methyl group, R3 represents either a (C1-C4)alkyl group or represents a phenyl(C1-C2)alkyl group optionally substituted on the ring by 2 to 3 methoxy groups, or represents a 2-(pyrid-2-yl)ethyl group, or else R2 and R3 form, with the nitrogen, either a 4-phenyl(piperid-1-yl)group or a 4-phenylmethyl(piperid-1-yl) group or a 1,2,3,4-tetrahydroisoquinol-2-yl group or a 6-methoxy-1,2,3,4-tetrahydroisoquinol-2-yl group or a 5,8-dimethoxy-1,2,3,4-tetrahydroisoquinol-2-yl group or a 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinol-2-yl group or a 2,3,4,5-tetrahydro-1H-3-benzazepin-3-yl group or a 7,8-dimethoxy-2,3,4,5-tetrahydro-1H-3-benzazepin-3-yl group and X represents either a carbonyl group or a sulphonyl group. Application in therapeutics.
</ABSTRACT>
<APPLICANTS>
</APPLICANTS>
<INVENTORS>
</INVENTORS>
<CLAIMS>
Compound, in the form of the pure optical isomer
or a mixture of optical isomers, corresponding to the

general formula (I)


in which

Y represents an atom of hydrogen, fluorine or chlorine or
a methyl or methoxy group,
R
1
 either represents a phenyl group which is substituted
with a fluorine atom or with a group chosen from among

the groups methyl, methoxy, trifluoromethyl and phenyl,
or represents a 2-thienyl group,
R
2
 represents a methyl group,
R
3
 either represents a (C
1
-C
4
)-alkyl group, or represents
a phenyl- (C
1
-C
2
)-alkyl group which is optionally
substituted on the ring by 2 to 3 methoxy groups, or

represents a 2-(2-pyridyl)ethyl group, or else
R
2
 and R
3
 form, with the nitrogen, either a
4-phenyl(1-piperidyl) group or a

4-phenylmethyl(1-piperidyl) group or a
1,2,3,4-tetrahydro-2-isoquinolyl group or a 6-methoxy-1,2,3,4-tetrahydro-2-isoquinolyl

group or a
5,8-dimethoxy-1,2,3,4-tetrahydro-2-isoquinolyl group or

a 6,7-dimethoxy-1,2,3,4-tetrahydro-2-isoquinolyl group or
a 2,3,4,5-tetrahydro-1H-3-benzazepin-3-yl group or a

7,8-dimethoxy-2,3,4,5-tetrahydro-1H-3-benzazepin-3-yl 
group, and
X either represents a carbonyl group or represents a
sulphonyl group,

and its addition salts with pharmaceutically acceptable
acids.
Compound according to Claim 1, characterized in
that R
1
 represents a 3-(trifluoromethyl)phenyl group,

R
2
 and R
3
 form, with the nitrogen, a 6,7-dimethoxy-1,2,3,4-tetrahydro-2-isoquinolyl
group, and
X represents a carbonyl group.
Process for the preparation of compounds
according to Claim 1, characterized in that


- when X represents a carbonyl group

a 2-aminophenol of general formula (II)


in which Y is as defined in Claim 1 is reacted with
trifluoroacetic anhydride in order to obtain the amide of

general formula (IV)


which is reacted with ethyl 4-bromobut-2-enoate, then the
ester functional group of ethyl 3,4-dihydro-2H-1,4-benzoxazine-3-acetate,

of general formula (VI)


is reduced in order to obtain the 3,4-dihydro-2H-1,4-benzoxazine-3-ethanol
of general formula (VII) 



which is reacted with an acid chloride of general formula
(VIII)


C1-CO-R
1

in which R
1
 is as defined in Claim 1 in order to obtain
an alcohol of general formula (IX)



which is reacted with thionyl chloride in order to obtain
a compound of general formula (X)



and, finally, the latter compound is reacted with an
amine of general formula (XI)



in which R
2
 and R
3
 are as defined in Claim 1,

or else
- when X represents a sulphonyl group
a 2-aminophenol of general formula (II)



in which Y is as defined in Claim 1 is reacted with a
chloride of general formula (III')


R
1
-SO
2
-C1

in which R
1
 is as defined in Claim 1 in order to obtain a
compound of general formula (IV') 



which is reacted with ethyl 4-bromobut-2-enoate, then the
ester functional group of the compound of general formula

(VI') is reduced in order to obtain a compound of general
formula (VII')



which is reacted with thionyl chloride in order to obtain
the compound of general formula (X')



which is finally condensed with an amine of general
formula (XI)



in which R
2
 and R
3
 are as defined in Claim 1.
Process according to Claim 3, characterized in
that the dextrorotatory and laevorotatory enantiomers of

the alcohols of general formulae (IX) and (VII') are
isolated by an enzymatic route before the synthesis is

continued.
Medicament, characterized in that it consists of
a compound according to Claim 1.
Pharmaceutical composition, characterized in that 
it contains a compound according to Claim 1 in

combination with any suitable excipient.
Compounds corresponding to the general formula
(XII)



in which

Y is as defined in Claim 1,
R either represents a hydrogen atom and R' represents a
2-hydroxyethyl group,
or R represents a group -COR
1
 in which R
1
 is a phenyl
group which is substituted by a fluorine atom or by a

group chosen from among the methyl, methoxy,
trifluoromethyl and phenyl groups, or is a 2-thienyl

group, and R' represents a 2-hydroxyethyl group or a 2-chloroethyl
group,
or R represents a group SO
2
R
1
 in which R
1
 is a phenyl
group which is substituted by a fluorine atom or by a

group chosen from among the methyl, methoxy,
trifluoromethyl and phenyl groups, or is a 2-thienyl

group, and R' represents a 2-hydroxyethyl group or a 2-chloroethyl
group or an ethoxycarbonylmethyl group,

which can be used for the synthesis of compounds
according to Claim 1.
</CLAIMS>
</TEXT>
</DOC>
